Results (
Indonesian) 1:
[Copy]Copied!
OXC (as both mono therapy and adjunctive therapy) hasshown efficacy in the treatment of partial onset seizures withepilepsy (Tripathi, 2010) and belongs to the category of BCS classII, and its dissolution is the rate-limiting step for absorption(Wellington, 2001). OXC is having half-life of 2h and iscompletely absorbed and extensively metabolized to itspharmacologically active 10-monohydroxy metabolite, which has ahalf-life of 9h.
Being translated, please wait..
